Antibody blocking of MHC II on human activated regulatory T cells abrogates their suppressive potential

被引:14
作者
Peiser, M. [1 ]
Becht, A. [1 ]
Wanner, R. [1 ]
机构
[1] Charite Univ Med Berlin, Inst Mol Biol & Bioinformat, D-14195 Berlin, Germany
关键词
dendritic cells; MHC II; regulatory T cells; vaccination;
D O I
10.1111/j.1398-9995.2007.01339.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Natural regulatory CD4(+)CD25(+)Foxp3(+) T cells control peripheral immune responses. Freshly isolated regulatory T-cell populations are regarded as being unable to suppress the proliferation of strongly stimulated effector T cells. We now provide evidence that it is not the strength of the proliferative signal to effector T cells but activation and accessibility of regulatory T cells that determine whether suppression may occur. Human regulatory T cells were initially cocultured with allogeneic monocyte-derived dendritic cells for a short time and were then rendered accessible for effector T cells by removal of the dendritic cells. That way activated regulatory T cells effectively suppressed the proliferation of autologous effector T cells which was strongly driven by cell-sized Dynabeads coated with CD3/CD28 antibodies. Although regulatory T cells are known to display MHC II molecules and to upregulate their expression along with activation, a role of MHC II molecules in forming the contact to effector T cells was not yet envisaged. However, blocking of MHC II on activated regulatory T cells abrogated their suppressive potential. It should not be excluded that self-MHC molecules on physically accessible activated regulatory T cells arrange the contact to effector T cells.
引用
收藏
页码:773 / 780
页数:8
相关论文
共 38 条
[1]   Natural regulatory T cells control the development of atherosclerosis in mice [J].
Ait-Oufella, H ;
Salomon, BL ;
Potteaux, S ;
Robertson, AKL ;
Gourdy, P ;
Zoll, J ;
Merval, R ;
Esposito, B ;
Cohen, JL ;
Fisson, S ;
Flavell, RA ;
Hansson, GK ;
Klatzmann, D ;
Tedgui, A ;
Mallat, Z .
NATURE MEDICINE, 2006, 12 (02) :178-180
[2]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[3]   Human CD4+CD25+ regulatory T cells [J].
Baecher-Allan, C ;
Viglietta, V ;
Hafler, DA .
SEMINARS IN IMMUNOLOGY, 2004, 16 (02) :89-97
[4]   CD4+CD25high regulatory cells in human peripheral blood [J].
Baecher-Allan, C ;
Brown, JA ;
Freeman, GJ ;
Hafler, DA .
JOURNAL OF IMMUNOLOGY, 2001, 167 (03) :1245-1253
[5]   MHC class II expression identifies functionally distinct human regulatory T cells [J].
Baecher-Allan, Clare ;
Wolf, Elizabeth ;
Haller, David A. .
JOURNAL OF IMMUNOLOGY, 2006, 176 (08) :4622-4631
[6]   Regulatory activity of human CD4+ CD25+ T cells depends on allergen concentration, type of allergen and atopy status of the donor [J].
Bellinghausen, I ;
König, B ;
Böttcher, I ;
Knop, J ;
Saloga, J .
IMMUNOLOGY, 2005, 116 (01) :103-111
[7]   Survival of mature CD4 T lymphocytes is dependent on major histocompatibility complex class II-expressing dendritic cells [J].
Brocker, T .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (08) :1223-1232
[8]   Survival and homeostatic proliferation of naive peripheral CD4+ T cells in the absence of self peptide:MHC complexes [J].
Clarke, SRM ;
Rudensky, AY .
JOURNAL OF IMMUNOLOGY, 2000, 165 (05) :2458-2464
[9]   CD4+CD25+ immunoregulatory T cells:: New therapeutics for graft-versus-host disease [J].
Cohen, JL ;
Trenado, A ;
Vasey, D ;
Klatzmann, D ;
Salomon, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (03) :401-406
[10]  
Davies JD, 1996, J IMMUNOL, V156, P3602